PAROXYSMAL AURICULAR TACHYCARDIA APPARENTLY RESULTING FROM COMBINED THYROID-IMIPRAMINE TREATMENT

doi:10.1176/appi.ajp.119.10.994

Am J Psychiatry 119:994-995, April 1963
doi: 10.1176/appi.ajp.119.10.994
© 1963 American Psychiatric Association



	Full Text (PDF)
	Alert me when this article is cited
	Alert me if a correction is posted



	Email this article to a Colleague
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new issues of the journal
	Add to My Articles & Searches
	Download to citation manager



	Citing Articles via HighWire
	Citing Articles via Google Scholar



	Articles by PRANGE, A. J.
	Search for Related Content



	PubMed Citation
	Articles by PRANGE, A. J., JR.

PAROXYSMAL AURICULAR TACHYCARDIA APPARENTLY RESULTING FROM COMBINED THYROID-IMIPRAMINE TREATMENT

ARTHUR J. PRANGE JR. M.D.¹

¹ Asst. Prof. of Psychiatry, School of Medicine, University of North Carolina.

Auricular tachycardia occurred during combined thyroid-imipraminetherapy. Animal studies suggest that the toxicity of both imipramineand MAO inhibitors may be increased in states of hyperthyroidlism.The mechanisms involved are under study.

This article has been cited by other articles:

N. P. Plotnikoff, A. J. Prange Jr., G. R. Breese, M. S. Anderson, and I. C. Wilson
Thyrotropin Releasing Hormone: Enhancement of Dopa Activity by a Hypothalamic Hormone
Science, October 27, 1972; 178(4059): 417 - 418.
[Abstract] [PDF]

Get information about faster international access.